Managing Director & Senior Partner
Munich
Judith Wallenstein leads Boston Consulting Group’s CEO Advisory work globally and in the Europe, Middle East, and South America region. She is a core member of BCG’s Health Care practice, notably serving fast-growing biotech companies. Judith co-leads BCG's Climate & Sustainability Moonshot and led the Social Impact and Sustainability practices in Central and Eastern Europe and the Middle East for two years.
Judith served as a BCG Fellow in 2015, during which time she examined the dynamics of the sharing economy and the future of work and implications on traditional corporations.
Judith’s pharma work centers on research and development, portfolio strategy and management, M&A, and product launch. She has been involved in some of the largest carve-out and divestiture efforts in the industry in recent years. Most of her client work is focused on oncology, vaccines, and rare disease.
Judith joined BCG's Munich office in 2000. She spent 18 months in the Madrid office and 12 months in the New York office as BCG Henderson Institute’s first ambassador in 2005. Her initial career plan had been to become a diplomat before an internship with BCG put her on a different track.
This reinsurance giant is using analytical data models to achieve its purpose of making the world more resilient.
Geopolitical uncertainty has a big impact on the food system, with massive implications for food security and sustainability. BCG’s Judith Wallenstein and Yara International’s Fernanda Lopes Larsen discuss how leaders are planning to tackle the issue.
Twenty years ago, CEOs could expect to spend about 10% to 15% of their time managing crises. Today, that percentage is much higher. BCG’s Judith Wallenstein talks to Andreas Berger, chief executive officer of corporate solutions at Swiss Re, about what this means for CEOs and other business leaders.